Cedar Ren

ABI3/VP1 proteins are members of a large group of transcription factors that act as intermediaries in regulating abscisic acid (ABA)-responsive genes during seed development, including those involved in reserve deposition, acquisition of desiccation tolerance and dormancy induction. CnABI3, an ABI3/VP1 gene homologue was recently cloned from yellow cedar, a conifer species that produces seeds that are deeply dormant at maturity. Here, we investigated whether the conifer ABI3/VP1 gene homologue shares characteristics with its angiosperm counterparts. CnABI3 was synthesized exclusively in seeds, with no detectable protein in leaves and roots. Stable expression of the CnABI3 gene in two transgenic tobacco lines previously transformed with chimeric constructs (vicilin and napin 5′ regions linked to a β-glucuronidase (GUS) gene-coding region) showed that the ectopic expression of the CnABI3 protein strongly activated both the vicilin and napin storage protein gene promoters in leaves and other vegetative tissues. GUS activities were up to more than 1000-fold of those in control plants. ABA had a synergistic effect, further enhancing GUS activity levels. When expressed transiently in yellow-cedar embryos, CnABI3 activated the expression of a chimeric Em-GUS gene in the presence of ABA. The role of CnABI3 in dormancy maintenance of yellow-cedar seeds was examined by monitoring the expression of the CnABI3 gene at the mRNA and protein levels before, during and after dormancy termination. CnABI3 protein was present in the megagametophyte and embryo of dormant mature and warm stratified seed, but declined during subsequent moist chilling, a treatment effective in breaking dormancy. In contrast, the protein was preserved (albeit in lower amounts) in seeds subjected to a control treatment (12 weeks in warm, moist conditions) that is ineffective in breaking dormancy. A decline in CnABI3 gene transcripts was also positively correlated with dormancy breakage, but did not occur during moist chilling itself, but rather during subsequent germination, indicating potential control at the post-transcriptional level.

To study severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.Clinical records of severe and rare complications following TACE in 1348 cases of liver cancer from January 1997 to February 2004 were studied retrospectively.A total of 2012 TACE procedures were performed for 1348 patients. There were 3 cases of spontaneous rupture of liver cancer, 1 case of perforation of duodenum, 3 cases of liver abscess (1 of them was associated with sepsis), 1 case of pulmonary embolism, 1 case of spasm of the hepatic artery, 40 cases of hepatic artery occlusion, 3 cases of femoral nerve injury, 1 case of bilioma and 1 case of acute renal failure.Although the severe complications of TACE are rare, the procedure should be done cautiously including super selection of hepatic artery, slow infusion of lipiodol, careful postoperative observations and early detection and management of complications.

PITUITARY TUMOR-TRANSFORMING gene (PTTG1) was first isolated from rat GH-secreting cells by differential RNA display (1). The human PTTG homolog (PTTG1) is a member of a gene family (2), and like its rat counterpart, human PTTG1 causes in vitro cell transformation ...

Newborn rats were injected intraperitoneally with uninfected human cells or cell infected with 56,000 pfu of varicella-zoster virus (VZV). Five to 6 weeks later, trigeminal ganglia were harvested and tested for VZV DNA and RNA by PCR. VZV gene 21 and 40 DNA were detected in most infected animals. Gene 21 RNA also was detected in ganglia from most infected animals, but not gene 40 RNA, paralleling previous observations in latently infected human ganglia. The neonatal rat may represent a useful new model for the study of VZV latency.

The pituitary transforming gene, PTTG, is abundantly expressed in endocrine neoplasms. PTTG has recently been recognized as a mammalian securin based on its biochemical homology to Pds1p. PTTG expression and intracellular localization were therefore studied during the cell cycle in human placental JEG-3 cells. PTTG mRNA and protein expressions were low at the G1/S border, gradually increased during S phase, and peaked at G2/M, but PTTG levels were attenuated as cells entered G1. In interphase cells, wild-type PTTG, an epitope-tagged PTTG, and a PTTG-EGFP conjugate all localized to both the nucleus and cytoplasm, but in mitotic cells, PTTG was not observed in the chromosome region. PTTG-EGFP colocalized with mitotic spindles in early mitosis and was degraded in anaphase. Intracellular fates of PTTG-EGFP and a conjugate of EGFP and a mutant inactivated PTTG devoid of an SH3-binding domain were observed by real-time visualization of the EGFP conjugates in live cells. The same cells were continuously observed as they progressed from G1/S border to S, G2/M, and G1. Most cells (67%) expressing PTTG-EGFP died by apoptosis, and few cells (4%) expressing PTTG-EGFP divided, whereas those expressing mutant PTTG-EGFP divided. PTTG-EGFP, as well as the mutant PTTG-EGFP, disappeared after cells divided. The results show that PTTG expression and localization are cell cycle-dependent and demonstrate that PTTG regulates endocrine tumor cell division and survival.